Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is budesonide ...

NANJING, China, February 20, 2025--(BUSINESS WIRE)--Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive ...

Crohn's disease belongs to a group of conditions known as inflammatory bowel diseases (IBD). This chronic condition causes ...

Background and Aim: Since the diagnostic value of ileoscopy is not well documented, it is uncertain if terminal ileum intubation should be performed routinely in patients undergoing colonoscopy.

Agomab’s ALK5 inhibitor has proven its ability to target the correct part of the intestine in a phase 2 trial of ...

U.S. authorities are investigating potential fraud in the 2022 sale of software business Mobileum, court papers show, raising the stakes of a legal fight between private-equity firms H.I.G. Capital ...

According to Kaleido Intelligence, total losses from fraud and security incidents will reach $45 billion in 2025. To combat ...

Perioperative optimization of nutrition leads to lower risks, better outcomes, and improved quality of life for patients.

Agomab Therapeutics NV (‘Agomab’) today announced positive interim results from 44 patients completing treatment in the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal ...

MyHealthTeam, a Swoop company, the creator of one of the largest, engaged patient social networks in healthcare, has ...